Literature DB >> 24647213

More medical comorbidities in patients with bipolar disorder from the United States than from the Netherlands and Germany.

Robert M Post1, Lori L Altshuler, Gabriele S Leverich, Mark A Frye, Trish Suppes, Susan L McElroy, Paul E Keck, Willem A Nolen, Ralph W Kupka, Heinz Grunze, Mike Rowe.   

Abstract

Medical comorbidities are common in patients with bipolar (BP) disorder but have not been previously examined for differences between United States and Europe. More than 900 outpatients with BP I and BP II disorder (mean age, 41 years) filled out a questionnaire including the occurrence of 30 listed medical conditions. The patients from the United States were from Los Angeles, Dallas, Cincinnati, and Bethesda, whereas those from Europe were from Utrecht, Freiberg, and Munich. Those from the United States had a significantly higher incidence of obesity and nine other medical comorbidities than those from Europe, who had only more cases of hyperthyroidism. The burden of medical comorbidities in patients with BP disorder from the United States seems higher than in patients from Europe. Given the adversities, morbidity, and early mortality associated with these conditions and their interaction with the morbidity and lethality of BP disorder itself, greater efforts at treatment and prevention of these medical comorbidities would seem indicated.

Entities:  

Mesh:

Year:  2014        PMID: 24647213     DOI: 10.1097/NMD.0000000000000116

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Authors:  Robert M Post; Lori L Altshuler; Gabriele S Leverich; Willem A Nolen; Ralph Kupka; Heinz Grunze; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Mike Rowe
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-18

2.  The Kindling/Sensitization Model and Early Life Stress.

Authors:  Robert M Post
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 3.  Management of bipolar I depression: clinical utility of lurasidone.

Authors:  Lillian Jan Findlay; Peggy El-Mallakh; Rif S El-Mallakh
Journal:  Ther Clin Risk Manag       Date:  2015-01-08       Impact factor: 2.423

4.  Effect of psychotic symptoms on cognitive impairment in patients with bipolar disorder.

Authors:  Rashmin Mansukh Achalia; Bhargavi Nagendra; Garimaa Achalia; Mahesh Chopade; Abhijit Sable; Ganesan Venkatasubramanian; Naren P Rao
Journal:  Ind Psychiatry J       Date:  2019-12-11

5.  How to prevent the malignant progression of bipolar disorder.

Authors:  Robert M Post
Journal:  Braz J Psychiatry       Date:  2020 Sep-Oct       Impact factor: 2.697

Review 6.  25 Years of the International Bipolar Collaborative Network (BCN).

Authors:  Robert M Post; Lori L Altshuler; Ralph Kupka; Susan L McElroy; Mark A Frye; Heinz Grunze; Trisha Suppes; Paul E Keck; Willem A Nolen
Journal:  Int J Bipolar Disord       Date:  2021-04-02

7.  Physical Comorbidity According to Diagnoses and Sex among Psychiatric Inpatients in South Korea.

Authors:  Suin Park; Go-Un Kim; Hyunlye Kim
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

8.  Prevalence and correlates of lifestyle behavior, anxiety and depression in Chinese college freshman: A cross-sectional survey.

Authors:  Chenchen Gao; Yumei Sun; Feifei Zhang; Fang Zhou; Chaoqun Dong; Ziwei Ke; Qingyan Wang; Yeqin Yang; Hongyu Sun
Journal:  Int J Nurs Sci       Date:  2021-06-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.